表紙
市場調查報告書

乳房病變位置鑑定法的全球市場 - 至2024年的預測:線式位置鑑定法、放射性同位素式位置鑑定法 (RSL、ROLL)、電磁式位置鑑定法、磁式位置鑑定法

Breast Lesion Localization Methods Market by Type (Wire, Radioisotope (Radio Occult), Magnetic), Usage (Tumor Identification, Sentinel Lymph Node (Lumpectomy)), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 356859
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
乳房病變位置鑑定法的全球市場 - 至2024年的預測:線式位置鑑定法、放射性同位素式位置鑑定法 (RSL、ROLL)、電磁式位置鑑定法、磁式位置鑑定法 Breast Lesion Localization Methods Market by Type (Wire, Radioisotope (Radio Occult), Magnetic), Usage (Tumor Identification, Sentinel Lymph Node (Lumpectomy)), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024
出版日期: 2019年05月16日內容資訊: 英文 103 Pages
簡介

乳房病變位置鑑定法市場,預計從2018年的4億1300萬美元到2024年擴大到5億9800萬美元,在預測期間中預計為6.3%的年複合成長率。該市場主要由乳癌發病率的上升,乳癌手術數量的增加,及乳癌的早期檢測相關認識的高漲所促進。可是,法規批審不確實的事,預計抑制在預測期間內的該市場的成長。

本報告提供乳房病變位置鑑定法市場相關調查分析,影響市場成長要素分析,各市場區隔及各地區/主要國家的市場的分析與預測,競爭情形分析,及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 課題

第5章 乳房病變位置鑑定法:各類型

  • 簡介
  • 線式定位法
  • 放射性同位素式定位法
    • RSL (放射性種子定位)
    • ROLL (放射線誘導式潛在性病變位置定位)
  • 電磁式位置鑑定法
  • 磁式位置鑑定法
  • 其他位置鑑定法

第6章 乳房病變位置鑑定法:各用途

  • 簡介
  • 腫瘤特定
  • 前哨淋巴節特定
    • 腫瘤切除手術
    • 乳房切除術

第7章 乳房病變位置鑑定法:各地區

  • 簡介
  • 亞太地區
  • 歐洲
  • 北美
    • 美國
    • 加拿大
  • 其他 (ROW)

第8章 競爭情形

  • 概要
  • 競爭領導製圖
  • 競爭模式
  • 終端用戶意向調查

第9章 企業簡介

  • OVERVIEW ARGON MEDICAL DEVICES
  • B.D. COMPANY
  • CIANNA MEDICAL
  • COOK MEDICAL
  • ENDOMAGNETICS LTD
  • HEALTH BEACON
  • INTRA-MEDICAL IMAGING LLC
  • ISOAID, LLC
  • LEICA BIOSYSTEMS
  • SOMATEX MEDICAL TECHNOLOGIES GMBH
  • SURGICEYE GMBH
  • RANFAC CORPORATION

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 4236

"The increasing incidence of breast cancer and number of breast cancer surgeries are expected to drive the overall growth of the breast lesion localization methods market."

The breast lesion localization methods market is expected to grow from USD 413 million in 2018 to USD 598 million by 2024, at a CAGR of 6.3% during the forecast period. The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period.

"The wire localization segment held the largest share of the breast lesion localization methods market in 2018."

Based on type, the breast lesion localization methods market is divided into five major segments-wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2018. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimum removal of normal tissues, minimal scarring, and the availability of reimbursement for breast lesion localization devices.

"Asia Pacific projected to grow at the highest CAGR during the forecast period."

The Asia Pacific is projected to record the highest growth in the breast lesion localization methods market during the forecast period. The rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness are the major factors supporting the growth of the Asia Pacific breast lesion localization methods market.

The report also contains a detailed analysis of end-user preference for the adoption of different breast lesion localization methods. The research findings cited in the report encapsulates the important selection criteria for breast lesion localization methods from an end-user point of view. It analyses importance given to the particular criteria while selecting a breast lesion localization methods. Important criteria for the selection of breast lesion localization methods include detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, and ease of use.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the breast lesion localization method market.

  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 48%, Europe: 24%, APAC: 19%, and the RoW: 9%

Some of the key players in the breast lesion localization methods market are C.R. Bard (US), Ranfac Corporation (US), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices (US), SurgicEye GmbH (Germany), Intra-Medical Imaging LLC (US), IsoAid, LLC (US), Cianna Medical (US), Endomagnetics Ltd. (UK), and Cook Medical (US). The study includes an in-depth competitive analysis of these key players in the breast lesion localization methods market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the breast lesion localization methods market across various segments. It aims at estimating the market size (in terms of volume) and the growth potential of this market across different segments by type, usage, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of breast lesion localization procedures market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DESIGN
  • 2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3 MARKET SIZE ESTIMATION
  • 2.4 PRIMARY RESEARCH (INTERVIEWS) - SAMPLING FRAME

3 EXECUTIVE SUMMARY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 RISING INCIDENCE OF BREAST CANCER
      • 4.2.1.2 INCREASING NUMBER OF BREAST CANCER SURGERIES
      • 4.2.1.3 INCREASING AWARENESS ON THE EARLY DETECTION OF BREAST CANCER
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 UNCERTAINTY IN REGULATORY APPROVAL PROCEDURES
      • 4.2.2.2 VISIONARY LEADERS
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED ELECTROMAGNETIC REFLECTORS
      • 4.2.3.1 DEARTH OF ONCOLOGISTS
    • 4.2.4 CHALLENGES
      • 4.2.4.1 DEARTH OF ONCOLOGISTS

5 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, MILLION PROCEDURES/USD MILLION (2016-2024)

  • 5.1 INTRODUCTION
  • 5.2 WIRE LOCALIZATION
  • 5.3 RADIOISOTOPE LOCALIZATION
    • 5.3.1 RADIOGUIDED OCCULT LESION LOCALIZATION
    • 5.3.2 RADIOACTIVE SEED LOCALIZATION
  • 5.4 ELECTROMAGNETIC LOCALIZATION
  • 5.5 MAGNETIC LOCALIZATION
  • 5.6 OTHER LOCALIZATION METHODS

6 BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, MILLION PROCEDURES (2016-2024)

  • 6.1 INTRODUCTION
  • 6.2 TUMOR IDENTIFICATION
  • 6.3 SENTINEL LYMPH NODE IDENTIFICATION
    • 6.3.1 LUMPECTOMY
    • 6.3.2 MASTECTOMY

7 BREAST LESION LOCALIZATION METHODS MARKET, BY REGION, MILLION PROCEDURES (2016-2024)

  • 7.1 INTRODUCTION
  • 7.2 ASIA PACIFIC
  • 7.3 EUROPE
  • 7.4 NORTH AMERICA
    • 7.4.1 US
    • 7.4.2 CANADA
  • 7.5 REST OF THE WORLD

8 COMPETITIVE LANDSCAPE

  • 8.1 OVERVIEW
  • 8.2 COMPETITIVE LEADERSHIP MAPPING
    • 8.2.1 STRENGTH OF PRODUCT PORTFOLIO
    • 8.2.2 BUSINESS STRATEGY EXCELLENCE
  • 8.3 COMPETITIVE SCENARIO
  • 8.4 END USER PREFERENCE STUDY
    • 8.4.1 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
    • 8.4.2 BREAST LESION LOCALIZATION METHODS: SELECTION CRITERIA EVALUATION
    • 8.4.3 QUALITATIVE ASSESSMENT OF REPLACEMENT TREND

9 COMPANY PROFILE

  • 9.1 OVERVIEW ARGON MEDICAL DEVICES
    • 9.1.1 BUSINESS OVERVIEW
    • 9.1.2 PRODUCT OFFERED
  • 9.2 B.D. COMPANY
    • 9.2.1 BUSINESS OVERVIEW
    • 9.2.2 BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
    • 9.2.3 PRODUCT OFFERED
    • 9.2.4 RECENT DEVELOPMENTS
  • 9.3 CIANNA MEDICAL
    • 9.3.1 BUSINESS OVERVIEW
    • 9.3.2 MERIT MEDICAL SYSTEMS, INC: COMPANY SNAPSHOT (2018)
    • 9.3.3 PRODUCT OFFERED
    • 9.3.4 RECENT DEVELOPMENTS
  • 9.4 COOK MEDICAL
    • 9.4.1 BUSINESS OVERVIEW
    • 9.4.2 PRODUCT OFFERED
  • 9.5 ENDOMAGNETICS LTD
    • 9.5.1 BUSINESS OVERVIEW
    • 9.5.2 PRODUCT OFFERED
    • 9.5.3 RECENT DEVELOPMENTS
  • 9.6 HEALTH BEACON
    • 9.6.1 BUSINESS OVERVIEW
    • 9.6.2 PRODUCT OFFERED
    • 9.6.3 RECENT DEVELOPMENTS
  • 9.7 INTRA-MEDICAL IMAGING LLC
    • 9.7.1 BUSINESS OVERVIEW
    • 9.7.2 PRODUCT OFFERED
  • 9.8 ISOAID, LLC
    • 9.8.1 BUSINESS OVERVIEW
    • 9.8.2 PRODUCT OFFERED
  • 9.9 LEICA BIOSYSTEMS
    • 9.9.1 BUSINESS OVERVIEW
    • 9.9.2 DANAHER: COMPANY SNAPSHOT (2018)
    • 9.9.3 BUSINESS OVERVIEW
    • 9.9.4 RECENT DEVELOPMENTS
  • 9.10 SOMATEX MEDICAL TECHNOLOGIES GMBH
    • 9.10.1 BUSINESS OVERVIEW
    • 9.10.2 PRODUCT OFFERED
    • 9.10.3 RECENT DEVELOPMENTS
  • 9.11 SURGICEYE GMBH
    • 9.11.1 BUSINESS OVERVIEW
    • 9.11.2 PRODUCT OFFERED
  • 9.12 RANFAC CORPORATION
    • 9.12.1 BUSINESS OVERVIEW
    • 9.12.2 PRODUCT OFFERED

10 APPENDIX

  • 10.1 DISCUSSION GUIDE
  • 10.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 10.4 AVAILABLE CUSTOMIZATIONS
  • 10.5 RELATED REPORTS
  • 10.6 AUTHORS DETAILS
: